போக்குகள் பகுப்பாய்வு அறிக்கை வழங்கியவர் கட்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article to reach USD 45.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.3% from 2021 to 2028. Increasing funding, investments in research and development, and successful product launches are boosting the market growth. Key suggestions from the report: By phase, the phase II segment held the largest share of over 50.0% in 2020 owing to the large number of therapies currently in development in phase II Based on indication, the oncology segment held the largest share of 47.0% in 2020 as oncology alone contributed to 600 CGT clinical trials out of around 1,000

United statesSouth africaSaudi arabiaSouth koreaGrand viewSan franciscoAsia pacificSherry jamesBristol myers squibbInternational corporationMedpace holdings incView research incSyneos healthView researchCharles river laboratoryGrand view research